#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute leukaemia Epstein-Barr virus infection Familial dilated cardiomyopathy Malignant fibrous histiocytoma Ocular lymphoma Juvenile chronic myelomonocytic leukaemia Adenocarcinoma gastric Osteomyelitis Dedifferentiated liposarcoma Mastocytosis Sexually transmitted disease Neonatal alloimmune thrombocytopenia T-cell type acute leukaemia B-cell lymphoma recurrent Small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Basic Information Marginal zone lymphoma – Treatment Factor VIII deficiency – Basic Information Mucopolysaccharidosis I – Treatment Fabry’s disease – Life with Disease Splenic marginal zone lymphoma – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease X-linked lymphoproliferative syndrome Krabbe’s disease Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SOFTISAN 378 Cenerimod Etravirine Acetic Acid, Glacial IHMA-2121771-2 ACARBOSE Tyra-300-B01 Delandistrogene Moxeparvovec A24110He Pentixafor Gallium Ga-68 Pervi-Fus Imgn151 Cetuximab Tx200-Tr101 Isis 696844 Clonidine Hydrochloride Acetazolamide Sodium Heparin Sodium Tocilizumab Neostigmine Methylsulfate More therapies…

    Learn about Your Condition

    HER2 positive breast cancer Endometriosis Onychomycosis T-cell lymphoma Tooth loss Obstructive airways disorder Diabetes insipidus Radiation skin injury Dyspepsia Corneal graft rejection Skin candida Myocarditis post infection Systemic scleroderma Diffuse large B-cell lymphoma Myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Short stature

  • Study of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Growth hormone deficiency
    • Short stature
    Investigated Drugs:
    • Somatropin
    • Lonapegsomatropin
    France Germany Italy Romania Spain

  • Study on the Effects of Vosoritide for Children with Idiopathic Short Stature

    Recruiting

    2 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Vosoritide
    France Germany Italy

  • Weekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Somatropin
    Czechia France Greece Poland

  • Study on the Effects of Somatropin and Letrozole in Boys with Short Predicted Height

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Somatropin
    • Letrozole
    Belgium

  • Study on the Effects of Somapacitan and Somatropin in Children with Short Stature Born Small for Gestational Age Without Catch-Up Growth by Age 2

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Somapacitan
    • Somatropin
    Austria France Hungary Italy Latvia

  • Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Noonan syndrome
    • Small for dates baby
    • Turner’s syndrome
    Investigated Drugs:
    • Somapacitan
    • Somatropin
    Austria Belgium Bulgaria Croatia Finland France +10
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!